Page last updated: 2024-08-21

alpha-aminopyridine and Adenocarcinoma

alpha-aminopyridine has been researched along with Adenocarcinoma in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's7 (63.64)24.3611
2020's3 (27.27)2.80

Authors

AuthorsStudies
Imaoka, S; Korekane, H; Miyamoto, Y; Noura, S; Ohue, M; Sasaki, Y; Tsuji, S1
Chao, YS; Chen, CN; Chen, JS; Chou, CH; Chu, SH; Wu, YH; Yang, MH1
Fernandez-Lozano, C; Liñares-Blanco, J; Munteanu, CR; Pazos, A1
Arai, Y; Hayashi, T; Kondo, A; Ninomiya, H; Shukuya, T; Suzuki, M; Takahashi, K; Takeshige, T; Ueda, S1
Hochmair, MJ; Prosch, H; Schwab, S1
Dong, L; Li, S; Xia, J; Zhang, J; Zhang, P; Zhang, X; Zhang, Y; Zhu, N1
Liang, YC; Liu, Q; Liu, T; Shi, LL; Wu, G; Wu, HG; Xue, HJ1
Herrera Loeza, SG; Kamande, JW; Moffitt, RA; Soper, SA; Tignanelli, CJ; Torphy, RJ; Yeh, JJ1
He, DH; Hochwald, SN; Zajac-Kaye, M; Zhang, J1
Kim, JE; Kim, W; Min, YH1
Begum, J; Cerveira, J; Crockford, A; Cuomo, ME; Dewhurst, SM; Encheva, V; Grönroos, E; McGranahan, N; Patel, H; Purewal, S; Renshaw, MJ; Snijders, AP; Swanton, C; Zalmas, LP1

Other Studies

11 other study(ies) available for alpha-aminopyridine and Adenocarcinoma

ArticleYear
Novel fucogangliosides found in human colon adenocarcinoma tissues by means of glycomic analysis.
    Analytical biochemistry, 2007, May-01, Volume: 364, Issue:1

    Topics: Acidic Glycosphingolipids; Adenocarcinoma; Aminopyridines; Biomarkers, Tumor; Carbohydrate Sequence; Chromatography, High Pressure Liquid; Colonic Neoplasms; Fucose; Gangliosides; Gels; Glycoside Hydrolases; Humans; Oligosaccharides, Branched-Chain; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry

2007
CC-01 (chidamide plus celecoxib) modifies the tumor immune microenvironment and reduces tumor progression combined with immune checkpoint inhibitor.
    Scientific reports, 2022, 01-20, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Aminopyridines; Animals; Antibodies, Monoclonal; Benzamides; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Drug Therapy, Combination; Immune Checkpoint Inhibitors; Interferon-gamma; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid-Derived Suppressor Cells; Neoplasm Invasiveness; Neoplastic Processes; Programmed Cell Death 1 Receptor; Tumor Microenvironment; Xenograft Model Antitumor Assays

2022
Molecular docking and machine learning analysis of Abemaciclib in colon cancer.
    BMC molecular and cell biology, 2020, Jul-08, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Algorithms; Aminopyridines; Benzimidazoles; Cell Line, Tumor; Colonic Neoplasms; Databases, Protein; Drug Repositioning; Epistasis, Genetic; Fatty Acid-Binding Proteins; Gastrointestinal Hormones; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Machine Learning; Molecular Docking Simulation; Neoplasm Staging; Prognosis; Survival Analysis

2020
Transformation from adenocarcinoma to squamous cell lung carcinoma with MET amplification after lorlatinib resistance: A case report.
    Thoracic cancer, 2021, Volume: 12, Issue:5

    Topics: Adenocarcinoma; Aminopyridines; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; Humans; Lactams; Middle Aged; Pyrazoles

2021
Complete remission of intrathecal metastases with lorlatinib therapy in a heavily pretreated ALK-positive lung cancer patient.
    Anti-cancer drugs, 2017, Volume: 28, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aminopyridines; Anaplastic Lymphoma Kinase; Female; Humans; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Middle Aged; Protein Kinase Inhibitors; Pyrazoles; Receptor Protein-Tyrosine Kinases; Spinal Cord Neoplasms

2017
Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report.
    BMC pulmonary medicine, 2018, Jan-23, Volume: 18, Issue:1

    Topics: Adenocarcinoma; Aminopyridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Crizotinib; Cytoskeletal Proteins; Gene Rearrangement; Humans; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Male; Middle Aged; Oncogene Fusion; Pemetrexed; Progression-Free Survival; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Pyrazoles; Time Factors

2018
Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2013, Volume: 33, Issue:6

    Topics: Adenocarcinoma; Aminopyridines; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gefitinib; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Matrix Metalloproteinase 9; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Quinazolines; RNA, Messenger; Vascular Endothelial Growth Factor A

2013
Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Adenocarcinoma; Aminopyridines; Animals; Antigens, Neoplasm; Biomarkers; Cell Adhesion Molecules; DNA Mutational Analysis; DNA Primers; Epithelial Cell Adhesion Molecule; Fluorescent Antibody Technique; Humans; Mice; Microfluidic Analytical Techniques; Morpholines; Neoplastic Cells, Circulating; Pancreatic Neoplasms; Statistics, Nonparametric

2014
A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells.
    Cell cycle (Georgetown, Tex.), 2014, Volume: 13, Issue:19

    Topics: Adenocarcinoma; Aminopyridines; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Humans; Hydroxamic Acids; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt

2014
The Aurora kinase A inhibitor TC-A2317 disrupts mitotic progression and inhibits cancer cell proliferation.
    Oncotarget, 2016, Dec-20, Volume: 7, Issue:51

    Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Aminopyridines; Aurora Kinase A; Cell Cycle; Cell Proliferation; Enzyme Inhibitors; Humans; Lung Neoplasms; M Phase Cell Cycle Checkpoints; Mitosis

2016
Cyclin D mediates tolerance of genome-doubling in cancers with functional p53.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 01-01, Volume: 28, Issue:1

    Topics: Adenocarcinoma; Aminopyridines; Benzimidazoles; Cell Line, Tumor; Colorectal Neoplasms; Cyclin C; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cytochalasin B; Diploidy; Flow Cytometry; Gene Knockdown Techniques; Genes, p53; HCT116 Cells; Humans; Protein Kinase Inhibitors; Tetraploidy; Tumor Suppressor Protein p53

2017